What sector does BioXcel Therapeutics, Inc (BTAI) operate in?
BioXcel Therapeutics, Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is BioXcel Therapeutics, Inc (BTAI) current stock price?
As of the latest data, BioXcel Therapeutics, Inc stock price is $1.49, with a previous close of $1.55. BioXcel Therapeutics, Inc lost -$0.06 in the last trading session, representing a -3.87% loss.
What is BioXcel Therapeutics, Inc (BTAI) current market capitalization?
BioXcel Therapeutics, Inc market cap is approximately 32.59 million.
What is BioXcel Therapeutics, Inc (BTAI) Earnings Per Share (EPS)?
The trailing EPS is -$9.29, and the forward EPS is -$2.63.
What is BioXcel Therapeutics, Inc (BTAI) EBITDA?
BioXcel Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -26.46 million.
Does BioXcel Therapeutics, Inc (BTAI) pay dividends?
No. BioXcel Therapeutics, Inc does not pay a dividend.
How did BioXcel Therapeutics, Inc (BTAI) perform in its most recent earnings report?
In the last report (September 30, 2025), BioXcel Therapeutics, Inc posted an EPS surprise of -2,322.22% and a revenue surprise of -54.77%.
What is BioXcel Therapeutics, Inc (BTAI) beta (volatility) score?
BioXcel Therapeutics, Inc has a beta of 0.228, indicating lower volatility than the overall market.